Duke Medical Schools Receives FDA Approval for Stem Cell Product

Tags: , , , , , ,

Duke University School of Medicine receives FDA approval of a stem cell product, called DUCORD, for patients with disorders affecting the body’s blood production system. They are currently conducting research into using cord blood stem cells to help heal a brain damaged by hydrocephalus. The research is being led by Dr. Joanne Kurtzberg, chief of the Division of Pediatric Blood and Marrow Transplantation at Duke. Dr. Kurtzberg hopes that this initial approval will allow for future approval for the use of cord blood stem cells into the treatment of hydrocephalus.

Click here to read the full article.

4 Comments for : Duke Medical Schools Receives FDA Approval for Stem Cell Product
  1. Reply

    Is this study looking for candidates with hydrocephalus?

    • Jennifer Bledsoe
    • April 22, 2019
    Reply

    Can I be part of your study I have hydrocephalus I am 49 years old and currently going through hell literally and desperately looking for some kind of solution

    • Nellie W.
    • April 18, 2018
    Reply

    Exciting news. My 12 year old daughter has congenital hydrocephalus. She underwent a successful ETV surgery combined with CPC when she was 5 months and has had no other brain surgery since. However, she has global developmental delays resulting from the damage to her brain. I too believe stem cell therapy would be of much benefit to her. We are in Kenya.

    • Kelleen Windsor
    • April 3, 2018
    Reply

    I have a 22 year old son who has just endured his 40th brain surgery for hydrocephalus..he also suffers slit ventricles and occulated ventricles and Chiari malformation..I believe stem cell therapy would make a difference and I will go to any extreme to help him..we are in Australia

Leave a Comment

Change this in Theme Options
Change this in Theme Options